Reply to Correspondence: What Is the Next Step for Patients With Aspirin‐Exacerbated Respiratory Disease: Biologics With or Without Aspirin Therapy?

Documenti analoghi

• An algorithm for the diagnosis and treatment of nonsteroidal antiinflammatory drugs hypersensitivity, 2024 update
  di: Inmaculada Doña, et al.
  Pubblicazione: (2024)
• Efficacy and Safety of a Three‐Step Aspirin Challenge Protocol for Diagnosis of Aspirin‐Exacerbated Respiratory Disease in a Monitored Clinic Setting
  di: Alexandria L. Irace, et al.
  Pubblicazione: (2026)
• Dupilumab‐Related Adverse Events and Intolerance in Aspirin‐Exacerbated Respiratory Disease Patients
  di: Lancelot P. Herpin, et al.
  Pubblicazione: (2026)
• Sputum Eosinophil and Macrophage Changes After Aspirin Challenge in Patients With Nonsteroidal Anti‐Inflammatory Drug–Exacerbated Respiratory Disease
  di: Gabriela Trąd‐Wójcik, et al.
  Pubblicazione: (2025)
• Urinary Leukotriene E4 as a Biomarker of Disease Burden in Aspirin‐Exacerbated Respiratory Disease: A Retrospective Cohort Study
  di: Alaa Alhalabi, et al.
  Pubblicazione: (2026)